Sevoflurane Source Market By Form (Vapor & Liquid), By Application (Inhalation Anesthesia, Outpatient Surgery, Veterinary Drugs, & Others), By End Use Industry (Clinics, Hospitals, Ambulatory Surgery Center, Pharmaceutical, & Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2022 - 2027

Report Code: CMR 43613 Report Format: PDF + Excel

Sevoflurane Source Market Overview

The sevoflurane source market size is estimated to reach US$250 million by 2027 after growing at a CAGR of around 1.7% from 2022 to 2027. The sevoflurane is general anesthesia that reduces the activity of central nervous system in the body. It is an ether compound that has fluoromethyl and 1, 1, 1, 3, 3, 3-hexafluroisopropyl as alkyl groups. The medical gases such as nitric oxide and oxygen are usually mixed with the precise concentration of anesthetic sevoflurane vapor and transported through carbon nanotubes to offer controlled flow got the patients. The growing demand of sevoflurane as inhalation anesthesia for surgeries is creating a drive in the sevoflurane source market. Furthermore, the rise in application of sevoflurane across various hospitals, pharmaceutical, surgical centers, and other end-use industries will offer major growth in the market during the forecast period.

Sevoflurane Source Market COVID-19 Impact

The covid outbreak had a major impact on the sevoflurane source market. The sevoflurane has major demand in various end-users such as hospitals, surgery center, clinics, and others. The healthcare sector faced major disruption and disturbed supply chain during the initial phase of pandemic. The admission of the covid infected patients in the hospitals increased, however the medical system was disturbed with low production of medical devices, shortages in raw materials, logistics disruptions, and other lockdown restrictions. Furthermore, with recovery in medical infrastructure and surgical technologies, the application of sevoflurane source increased. According to the Centers for Medicare & Medicaid Services (CMS), the hospital spending increased by 6.4% in 2020, reaching USD 1.3 trillion in 2020. This led to growth opportunities in the market during the later phase of pandemic. Thus, the global sevoflurane source industry experienced major demand post pandemic.

Report Coverage

The report: “Sevoflurane Source Market Report– Forecast (2022-2027)” by IndustryARC covers an in-depth analysis of the following segments of the global sevoflurane source industry.

By Form: Vapor and Liquid.
By Application: Inhalation Anesthesia, Outpatient Surgery, Veterinary Drugs, and Others.
By End Use Industry: Clinics, Hospitals, Ambulatory Surgery Center, Pharmaceutical, and Others.
By Geography: North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and New Zealand, Indonesia, Taiwan, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), Middle East (Saudi Arabia, UAE, Israel, Rest of the Middle East) and Africa (South Africa, Nigeria, Rest of Africa)

Key Takeaways

  • The sevoflurane source market size will increase owing to its rising application for surgical procedures, general anesthesia, veterinary drugs, and others during the forecast period.
  • The North America is the fastest growing region in the global sevoflurane source industry due to increasing demand from surgical procedures, growth in hospital infrastructure, and rising number of chronic diseases in this region, thereby boosting the growth in the market.
  • The rise in surgical procedures and treatment of various chronic diseases is boosting the demand of sevoflurane for inhalation anesthetics as induction and maintenance of the general anesthesia.

Figure: North America Sevoflurane Source Market Revenue, 2021-2027 (US$ Million)


For more details on this report - Request for Sample

Sevoflurane Source Market Segment Analysis – By Application

By application, the inhalation anesthesia segment accounted for the largest share in the sevoflurane source market and is expected to grow with a CAGR of around 2.2% during the forecast period. The growth of sevoflurane is influenced by its increasing application for general anesthesia during surgeries as induction and maintenance of the general anesthesia. The inhalation anesthetic medications such as nitric oxide, sevoflurane, and others are used for geriatric population, paediatric, and other age grouped. Furthermore, the growing application for inhalation anesthesia is influenced by the surge in surgical procedures for emergency cases and accidents. According to the Healthcare Cost and Utilization Project (HCUP), the encounter for the major ambulatory surgeries undertaken in hospital facilities accounted for 11.9 million in 2019. Thus, with growing demand for sevoflurane in general anesthetic application in surgeries and other diagnostic disorders, the sevoflurane source market will grow during the forecast period. 

Sevoflurane Source Market Segment Analysis – By End-Use Industry

By end-use industry, the hospitals segment held the largest sevoflurane source market share and is expected to grow with a CAGR of over 1.5% during the forecast period. The demand of sevoflurane is high in the hospital end-users owing to its growing application in surgeries, diseases treatment procedures, and others. This fluoromethyl 2, 2, 2,-trifluoro-1-(trifluoromethyl) ethyl ether offers applications in maintenance and induction of anesthetics in hospitals. The sevoflurane increases the cyclic guanosine monophosphate level of the brain and also creates a rise in cerebral blood flow. Moreover, the growing demand of anesthetic in health conditions such as respiratory disorders, cancer, gastrointestinal disorders, and others is influencing the growth of sevoflurane source industry. According to the American Hospital Association (AHA), the AHA annual survey described total 6,093 U.S hospitals in 2020, with total expenses of all U.S. hospital accounting for USD 1.2 trillion. Thus, with rising application of sevoflurane as anesthetics for surgeries, treatment program procedures, and others in hospital sector, along with growing development in hospital infrastructure, the sevoflurane source market will grow rapidly during the forecast period. 

Sevoflurane Source Market Segment Analysis – By Geography

By geography, the North America is the fastest-growing region in the sevoflurane source market and is expected to grow with a CAGR of around 2.7% during the forecast period. The robust growth of sevoflurane in this region is influenced by the surge in applications for emerging accidental cases, cancer, and other diagnostic disorders. The rise in the healthcare infrastructure and advancement in hospitals and surgical procedures is influencing the growth for sevoflurane source market. According to the World Bank, the health expenditure in 2019 accounted for 16.32% of the GDP in North America. Furthermore, with major development in anesthetic delivery systems and growing hospital sector, the demand for sevoflurane in general anesthesia will rise. Thus, with major demand of sevoflurane in hospitals and pharmaceutical industry, the global sevoflurane source industry will experience major growth during the forecast period.

Sevoflurane Source Market Drivers

Rising adoption in surgical procedures

The sevoflurane has growing application in the surgeries as they work by stimulating the inhibitory neurohormones and maintains the anesthetic effects during the surgical procedures. The high demand of inhalation anesthetics such a sevoflurane, isoflurane, and others for treatment of various diseases such as cancer treatment, respiratory diseases, and others is driving the sevoflurane source market. According to the Plastic Society Of Plastic Surgeons, around 6.8 million reconstructive procedures, 211,067 liposuction surgical procedures, and 5.2 million tumor removal procedure were performed in 2020. Thus, the rise in surgical procedures and development in hospitals, ambulatory surgical centers, and others is offering major growth in the sevoflurane source market.

Growing healthcare sector

The sevoflurane source market has rising demand in the hospital, ambulatory surgery center, veterinary drugs, and others in the healthcare sector. The rapid development and advancement in the medical sector is creating a drive for the sevoflurane source market. The rise in surgical procedure and technologies is boosting the demand for inhalation anesthetics. According to India Brand Equity Foundation (IBEF), the healthcare sector in India is expected to reach around USD 372 billion by the year 2022. Thus, the growth in medical technologies and healthcare sector is offering major growth opportunities in the  sevoflurane source market.

Sevoflurane Source Market Challenges

Hazardous environmental effects

The demand for inhalation anesthetic is growing owing to its efficiency and performance in general anesthesia maintenance. However, the harmful effects of inhalation anesthetic gases such as sevoflurane, nitric oxide, isoflurane, and others is creating a major challenge for the growth of sevoflurane in the market. The higher concentration of these volatile gases destructs the ozone layer and leads to global warming. For instance, the American Conference of Government Industrial Hygienist (ACGIH) has stated a non-regulatory occupational limit for exposure of 50 ppm for isoflurane. Thus, the harmful impact of sevoflurane inhalation gas in the environment is hindering the demand and growth prospects in the market.

Sevoflurane Source Industry Outlook

The global sevoflurane source top 10 companies include:

  1. Baxter Healthcare Corp.
  2. Abbott Laboratories
  3. Jiangsu Hengrui
  4. Lunan
  5. Maruishi Pharmaceutical
  6. Piramal Enterprises Limited
  7. Fresenius Kabi AG
  8. Hikima Pharmaceutical PLC
  9. AbbVie Inc.
  10. Shanghai Hengrui

Recent Developments

  • In January 2022, the Dechra acquired the veterinary products that included sevoflurane and isoflurane from the Halocarbon with the aim to expand the veterinary surgical and anesthetics portfolio.
  • In September 2020, the NorthStar Anesthesia completed the acquisition of the Surgery Partners, Inc. This acquisition aimed to expand the growth and anesthetics services in the market.
  • In July 2020, the Baxter announced the partnership with the Zeosys Medical in order to bring the environment friendly and innovative anesthesia gas recapture technology to the hospitals.

Relevant Reports

Breathing Circuits Market - Forecast(2022 - 2027)
Report Code: HCR 73072

Anaesthesia Machines Market - Forecast(2022 - 2027)
Report Code: HCR 0118

Benzocaine Market - Forecast(2022 - 2027)
Report Code: CMR 0989 


For more Chemicals and Materials related reports, please click here

1. Sevoflurane Source Market- Market Overview
    1.1 Definitions and Scope
2. Sevoflurane Source Market - Executive Summary
    2.1 Key Trends by Form
    2.2  Key Trends by Application
    2.3  Key Trends by End-Use Industry
    2.4  Key Trends by Geography
3. Sevoflurane Source Market – Comparative analysis
    3.1 Market Share Analysis- Major Companies
    3.2 Product Benchmarking- Major Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis- Major Companies
    3.5 Pricing Analysis (ASPs will be provided)
4. Sevoflurane Source Market - Startup companies Scenario Premium  Premium
    4.1 Major startup company analysis:
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Product portfolio
        4.1.4 Venture Capital and Funding Scenario
5. Sevoflurane Source Market – Industry Market Entry Scenario Premium  Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Successful Venture Profiles
    5.4 Customer Analysis – Major companies
6. Sevoflurane Source Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Buyers
        6.3.3 Threat of New Entrants
        6.3.4 Competitive Rivalry
        6.3.5 Threat of Substitutes
7. Sevoflurane Source Market – Strategic Analysis
    7.1  Value/Supply Chain Analysis
    7.2 Opportunity Analysis
    7.3 Product/Market Life Cycle
    7.4 Distributor Analysis – Major Companies
8. Sevoflurane Source Market – By Form (Market Size -$Million/Billion)
    8.1 Vapor
    8.2 Liquid
9. Sevoflurane Source Market – By Application (Market Size -$Million/Billion
    9.1 Inhalation Anesthesia
    9.2 Outpatient Surgery
    9.3 Veterinary Drugs
    9.4 Others
10. Sevoflurane Source Market - By End-Use Industry (Market Size -$Million/Billion)
    10.1 Clinics
    10.2 Hospitals
    10.3 Ambulatory Surgery Center
    10.4 Pharmaceutical
    10.5 Others
11. Sevoflurane Source Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 USA
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 UK
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Netherlands
        11.2.6 Spain
        11.2.7 Russia
        11.2.8 Belgium
        11.2.9 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 India
        11.3.4 South Korea
        11.3.5 Australia and New Zeeland
        11.3.6 Indonesia
        11.3.7 Taiwan
        11.3.8 Malaysia
        11.3.9 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Colombia
        11.4.4 Chile
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
            11.5.1.1 Saudi Arabia
            11.5.1.2 UAE
            11.5.1.3 Israel
            11.5.1.4 Rest of the Middle East
        11.5.2 Africa
            11.5.2.1 South Africa
            11.5.2.2 Nigeria
            11.5.2.3 Rest of Africa
12. Sevoflurane Source Market – Entropy
    12.1 New Product Launches
    12.2 M&As, Collaborations, JVs and Partnerships
13. Sevoflurane Source Market – Industry/Competition Segment Analysis Premium
    13.1Company Benchmarking Matrix – Major Companies
    13.2 Market Share at Global Level - Major companies
    13.3 Market Share by Key Region - Major companies
    13.4 Market Share by Key Country - Major companies
    13.5 Market Share by Key Application - Major companies
    13.6 Market Share by Key Product Type/Product category - Major companies
14. Sevoflurane Source Market – Key Company List by Country Premium Premium
15. Sevoflurane Source Market Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials would be provided on a best effort basis for private companies"

LIST OF TABLES

1.Global Sevoflurane Source Market, by Type Market 2019-2024 ($M)
2.Global Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)
3.Global Sevoflurane Source Market, by Type Market 2019-2024 (Volume/Units)
4.Global Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 (Volume/Units)
5.North America Sevoflurane Source Market, by Type Market 2019-2024 ($M)
6.North America Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)
7.South America Sevoflurane Source Market, by Type Market 2019-2024 ($M)
8.South America Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)
9.Europe Sevoflurane Source Market, by Type Market 2019-2024 ($M)
10.Europe Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)
11.APAC Sevoflurane Source Market, by Type Market 2019-2024 ($M)
12.APAC Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)
13.MENA Sevoflurane Source Market, by Type Market 2019-2024 ($M)
14.MENA Sevoflurane Source Market Analysis and Forecast by Type and Application Market 2019-2024 ($M)

LIST OF FIGURES

1.US Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
2.Canada Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
3.Mexico Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
4.Brazil Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
5.Argentina Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
6.Peru Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
7.Colombia Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
8.Chile Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
9.Rest of South America Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
10.UK Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
11.Germany Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
12.France Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
13.Italy Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
14.Spain Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
15.Rest of Europe Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
16.China Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
17.India Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
18.Japan Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
19.South Korea Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
20.South Africa Global Sevoflurane Source Market Revenue, 2019-2024 ($M)
21.North America Global Sevoflurane Source Industry By Application
22.South America Global Sevoflurane Source Industry By Application
23.Europe Global Sevoflurane Source Industry By Application
24.APAC Global Sevoflurane Source Industry By Application
25.MENA Global Sevoflurane Source Industry By Application